Craft

Advanced
MedDay

MedDay

Total Funding

$48.9 M

MedDay Summary

Company Summary

Overview
MedDay is a biotechnology company, which develops new drugs for neurological and psychiatric diseases. It provides MD1003, a solution for the treatment of primary and secondary progressive multiple sclerosis; MD1103, a solution for autism spectrum disorders; and MD1105, a solution for Alzheimer’s disease.
Type
Private
Status
Active
Founded
2011
HQ
Clichy, FR | view all locations
Website
http://medday-pharma.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Frédéric Sedel

    Frédéric Sedel, Chief Scientific Officer and Co-Founder

    • Catherine Moukheibir

      Catherine Moukheibir, Chairman of the Board

      • Hermine Cadence

        Hermine Cadence, Finance Director Group

        • Frederick Munschauer

          Frederick Munschauer, Vice President, Global Head of Medical

          LocationsView all

          3 locations detected

          • Clichy, IDF HQ

            France

            8 Rue Henri Poincaré

          • Boston, MA

            United States

            745 Boylston St #405

          • Paris, Île-de-France

            France

            24 Rue de la Pépinière

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX